Stevanato Group Spa stock is traded at $14.36, with a volume of 879,108. It is up +3.24% in the last 24 hours and down -25.44% over the past month. Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
Previous Close:
$13.91
Open:
$13.80
24h Volume:
879,108
Relative Volume:
0.44
Market Cap:
$3.92B
Revenue:
$1.40B
Net Income/Loss:
$164.00M
P/E Ratio:
23.90
EPS:
$0.6009
Net Cash Flow:
-$11.09M
1W Performance:
+5.82%
1M Performance:
-25.44%
6M Performance:
-19.60%
1Y Performance:
-36.63%
1-Day Range:
$13.80$14.76
1-Week Range:
$13.18$14.76
52-Week Range:
$12.05$24.51
Stevanato Group Spa Stock (STVN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS